Dexamethasone as a Treatment of COVID-19
- https://doi.org/10.2991/dsahmj.k.201125.001How to use a DOI?
- COVID-19, SARS-CoV-2, cytokine storm, dexamethasone
Severe acute respiratory syndrome coronavirus 2 is the causative agent of coronavirus disease 2019 (COVID-19), one of the fatal pandemic diseases in the 20th and 21st centuries. Given the absence of definitive treatment, computational and clinical repurposing of drugs was practiced to combat this disease. Cytokine storm was cited as the primary cause of death during COVID-19. In this context, corticosteroid drugs such as dexamethasone attracted considerable interest in treating this viral infection. In general, based on current studies, dexamethasone appears to be a safe and effective treatment option for moderate or severe respiratory diseases caused by COVID-19.
- © 2020 Dr. Sulaiman Al Habib Medical Group. Publishing services by Atlantis Press International B.V.
- Open Access
- This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
Cite this article
TY - JOUR AU - Abdullah Alkattan AU - Mahmoud Kandeel PY - 2020 DA - 2020/12 TI - Dexamethasone as a Treatment of COVID-19 JO - Dr. Sulaiman Al Habib Medical Journal SN - 2590-3349 UR - https://doi.org/10.2991/dsahmj.k.201125.001 DO - https://doi.org/10.2991/dsahmj.k.201125.001 ID - Alkattan2020 ER -